Personal Attention, Proven Results Since 1953

Abbott Labs agrees to pay $1.6 billion to settle Depakote cases

Published on May 9, 2012 at 2:14 pm in Consumer Awareness.

Abbott Laboratories has agreed to pay $1.6 billion to settle claims that the company improperly marketed its neurological medication Depakote. The drug, approved to treat epilepsy, bipolar disorder and migraines, was allegedly marketed to treat schizophrenia, dementia and autism, a group of whistle-blower lawsuits claimed. The suits also said the company gave illegal kickbacks to doctors for talking about the off-label uses.  https://www.latimes.com/business/la-fi-abbott-depakote-20120507,0,7598749.story

Free Case Evaluations

Disclaimer: Some non-personal injury related cases do require a consultation fee.

Call us or fill out the form below to tell us about your potential case and a personal injury lawyer will get back to you as quickly as possible.